Spray-freeze-dried inhalable composite microparticles containing nanoparticles of combinational drugs for potential treatment of lung infections caused by Pseudomonas aeruginosa
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Spray-freeze-dried inhalable composite microparticles containing nanoparticles of combinational drugs for potential treatment of lung infections caused by Pseudomonas aeruginosa
Authors
Keywords
Colistin, Ivacaftor, Cystic fibrosis, Pseudomonas aeruginosa, Dry powder inhaler, In vitro, dissolution
Journal
INTERNATIONAL JOURNAL OF PHARMACEUTICS
Volume 610, Issue -, Pages 121160
Publisher
Elsevier BV
Online
2021-10-06
DOI
10.1016/j.ijpharm.2021.121160
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- In vitro evaluation of drug delivery behavior for inhalable amorphous nanoparticle formulations in a human lung epithelial cell model
- (2021) Jianting Chen et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- Particle engineering principles and technologies for pharmaceutical biologics
- (2021) Dongmei Cun et al. ADVANCED DRUG DELIVERY REVIEWS
- Enhancing Betulinic Acid Dissolution Rate and Improving Antitumor Activity via Nanosuspension Constructed by Anti-Solvent Technique
- (2020) Shuqi Li et al. Drug Design Development and Therapy
- Glibenclamide nanosuspension inhaler: development, in vitro and in vivo assessment
- (2020) Fahima M. Hashem et al. DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY
- Isoliquiritigenin Nanosuspension Enhances Cytostatic Effects in A549 Lung Cancer Cells
- (2020) Fangxia Qiao et al. PLANTA MEDICA
- Effect of formulation and inhaler parameters on the dispersion of spray freeze dried voriconazole particles
- (2020) Qiuying Liao et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- Formulation aspects of intravenous nanosuspensions
- (2020) Dipeekakumari Patel et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- Optimization of inhalable liposomal powder formulations and evaluation of their in vitro drug delivery behavior in Calu-3 human lung epithelial cells
- (2020) Shihui Yu et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- Inhalable Nanocomposite Microparticles with Enhanced Dissolution and Superior Aerosol Performance
- (2020) Chune Zhu et al. MOLECULAR PHARMACEUTICS
- Dry powder aerosol containing muco-inert particles for excipient enhanced growth pulmonary drug delivery
- (2020) Guihong Chai et al. Nanomedicine-Nanotechnology Biology and Medicine
- Characterization of excipient enhanced growth (EEG) tobramycin dry powder aerosol formulations
- (2020) Amr Hassan et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- Antimicrobial Activity of α-Peptide/β-Peptoid Lysine-Based Peptidomimetics Against Colistin-Resistant Pseudomonas aeruginosa Isolated From Cystic Fibrosis Patients
- (2019) Natalia Molchanova et al. Frontiers in Microbiology
- Efficacy of ceftolozane/tazobactam, alone and in combination with colistin, against multidrug-resistant Pseudomonas aeruginosa in an in vitro biofilm pharmacodynamic model
- (2019) Joan Gómez-Junyent et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Evaluation of in vitro activity of ceftolozane-tazobactam compared to other antimicrobial agents against Pseudomonas aeruginosa isolates from cystic fibrosis patients
- (2019) Giovanni Gherardi et al. DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE
- Successful adjunctive use of bacteriophage therapy for treatment of multidrug-resistant Pseudomonas aeruginosa infection in a cystic fibrosis patient
- (2019) Nancy Law et al. INFECTION
- Porous and highly dispersible voriconazole dry powders produced by spray freeze drying for pulmonary delivery with efficient lung deposition
- (2019) Qiuying Liao et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- Sustained release of a model water-soluble compound via dry powder aerosolizable acetalated dextran microparticles
- (2019) Nishan K. Shah et al. PHARMACEUTICAL DEVELOPMENT AND TECHNOLOGY
- Resistance and Heteroresistance to Colistin in Pseudomonas aeruginosa Isolates from Wenzhou, China
- (2019) Jie Lin et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Correlations between surface composition and aerosolization of jet-milled dry powder inhaler formulations with pharmaceutical lubricants
- (2019) Sharad Mangal et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- Clinical outcomes for cystic fibrosis patients with Pseudomonas aeruginosa cross‐infections
- (2019) Justyna Milczewska et al. PEDIATRIC PULMONOLOGY
- Cystic fibrosis lung disease and bronchiectasis
- (2019) James D Chalmers Lancet Respiratory Medicine
- The future of cystic fibrosis care: a global perspective
- (2019) Scott C Bell et al. Lancet Respiratory Medicine
- Evaluation of co-delivery of colistin and ciprofloxacin in liposomes using an in vitro human lung epithelial cell model
- (2019) Guihong Chai et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- Ivacaftor in cystic fibrosis with residual function: Lung function results from an N-of-1 study
- (2019) Jerry A. Nick et al. Journal of Cystic Fibrosis
- Cystic Fibrosis Lung Disease: An Overview
- (2019) Nelson L Turcios Respiratory Care
- Transformation of Meloxicam Containing Nanosuspension into Surfactant-Free Solid Compositions to Increase the Product Stability and Drug Bioavailability for Rapid Analgesia
- (2019) Csaba Bartos et al. Drug Design Development and Therapy
- Tezacaftor and ivacaftor for the treatment of cystic fibrosis
- (2019) Sarah L. Paterson et al. Expert Review of Respiratory Medicine
- Physical stability of dry powder inhaler formulations
- (2019) Nivedita Shetty et al. Expert Opinion on Drug Delivery
- Inhalable liposomal powder formulations for co-delivery of synergistic ciprofloxacin and colistin against multi-drug resistant gram-negative lung infections
- (2019) Shihui Yu et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- Development of a Resveratrol Nanosuspension Using the Antisolvent Precipitation Method without Solvent Removal, Based on a Quality by Design (QbD) Approach
- (2019) Do-Hoon Kuk et al. Pharmaceutics
- Budesonide nanocrystal-loaded hyaluronic acid microparticles for inhalation: In vitro and in vivo evaluation
- (2018) Tingting Liu et al. CARBOHYDRATE POLYMERS
- Formulation techniques for high dose dry powders
- (2018) Ashlee D. Brunaugh et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- Development of spray-freeze-dried siRNA/PEI powder for inhalation with high aerosol performance and strong pulmonary gene silencing activity
- (2018) Tomoyuki Okuda et al. JOURNAL OF CONTROLLED RELEASE
- Qualitative and Quantitative Characterization of Composition Heterogeneity on the Surface of Spray Dried Amorphous Solid Dispersion Particles by an Advanced Surface Analysis Platform with High Surface Sensitivity and Superior Spatial Resolution
- (2018) Sonal V. Bhujbal et al. MOLECULAR PHARMACEUTICS
- Effects of Moisture-Induced Crystallization on the Aerosol Performance of Spray Dried Amorphous Ciprofloxacin Powder Formulations
- (2018) Nivedita Shetty et al. PHARMACEUTICAL RESEARCH
- Preparation and Characterization of Stable Nanosuspension for Dissolution Rate Enhancement of Furosemide: A Quality by Design (QbD) Approach
- (2018) Akbar L. Marzan et al. Current Drug Delivery
- Ultrasonic spray-freeze drying of partially purified microbial transglutaminase
- (2018) Hilal Isleroglu et al. FOOD AND BIOPRODUCTS PROCESSING
- Co-Delivery of Ciprofloxacin and Colistin in Liposomal Formulations with Enhanced In Vitro Antimicrobial Activities against Multidrug Resistant Pseudomonas aeruginosa
- (2018) Shaoning Wang et al. PHARMACEUTICAL RESEARCH
- Nanosponges –A Promising Novel Drug Delivery System
- (2018) Parijat Pandey et al. Recent Patents on Nanotechnology
- Ivacaftor, a Cystic Fibrosis Transmembrane Conductance Regulator Potentiator, Enhances Ciprofloxacin Activity Against Pseudomonas aeruginosa
- (2018) Do-Yeon Cho et al. American Journal of Rhinology & Allergy
- Understanding the Impacts of Surface Compositions on the In-Vitro Dissolution and Aerosolization of Co-Spray-Dried Composite Powder Formulations for Inhalation
- (2018) Sharad Mangal et al. PHARMACEUTICAL RESEARCH
- Prospective, comparative clinical study between high-dose colistin monotherapy and colistin–meropenem combination therapy for treatment of hospital-acquired pneumonia and ventilator-associated pneumonia caused by multidrug-resistant Klebsiella pneumoniae
- (2018) Mohamed Farouk Ahmed Abdelsalam et al. Journal of Global Antimicrobial Resistance
- The safety of lumacaftor and ivacaftor for the treatment of cystic fibrosis
- (2017) Maria Talamo Guevara et al. Expert Opinion On Drug Safety
- Formulation and characterization of biocompatible and stable I.V. itraconazole nanosuspensions stabilized by a new stabilizer polyethylene glycol-poly(β-Benzyl- l -aspartate) (PEG-PBLA)
- (2017) Lanlan Zong et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- Tezacaftor–Ivacaftor in Residual-Function Heterozygotes with Cystic Fibrosis
- (2017) Steven M. Rowe et al. NEW ENGLAND JOURNAL OF MEDICINE
- Lumacaftor/Ivacaftor: A Review in Cystic Fibrosis
- (2016) Emma D. Deeks DRUGS
- Inhaled drug treatment for tuberculosis: Past progress and future prospects
- (2016) A.J. Hickey et al. JOURNAL OF CONTROLLED RELEASE
- Polymeric Amorphous Solid Dispersions: A Review of Amorphization, Crystallization, Stabilization, Solid-State Characterization, and Aqueous Solubilization of Biopharmaceutical Classification System Class II Drugs
- (2016) Shrawan Baghel et al. JOURNAL OF PHARMACEUTICAL SCIENCES
- An “Unlikely” Pair: The Antimicrobial Synergy of Polymyxin B in Combination with the Cystic Fibrosis Transmembrane Conductance Regulator Drugs KALYDECO and ORKAMBI
- (2016) Elena K. Schneider et al. ACS Infectious Diseases
- Effects of Surface Composition on the Aerosolisation and Dissolution of Inhaled Antibiotic Combination Powders Consisting of Colistin and Rifampicin
- (2015) Wenbo Wang et al. AAPS Journal
- Inhaled formulations and pulmonary drug delivery systems for respiratory infections
- (2015) Qi (Tony) Zhou et al. ADVANCED DRUG DELIVERY REVIEWS
- Nanoembedded Microparticles for Stabilization and Delivery of Drug-Loaded Nanoparticles
- (2015) Adam Bohr et al. CURRENT PHARMACEUTICAL DESIGN
- Powder Production and Particle Engineering for Dry Powder Inhaler Formulations
- (2015) Yu-Wei Lin et al. CURRENT PHARMACEUTICAL DESIGN
- Preparation, optimization, and in vitro simulated inhalation delivery of carvedilol nanoparticles loaded on a coarse carrier intended for pulmonary administration
- (2015) Aly Abdelbary et al. International Journal of Nanomedicine
- Ivacaftor as salvage therapy in a patient with cystic fibrosis genotype F508del/R117H/IVS8-5T
- (2015) S. Carter et al. Journal of Cystic Fibrosis
- Pseudomonas aeruginosa in Cystic Fibrosis Patients With G551D-CFTR Treated With Ivacaftor
- (2014) Sonya L. Heltshe et al. CLINICAL INFECTIOUS DISEASES
- Spray freeze drying for dry powder inhalation of nanoparticles
- (2014) Mohamed Ehab Ali et al. EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS
- Colistin Powders with High Aerosolisation Efficiency for Respiratory Infection: Preparation and In Vitro Evaluation
- (2013) Qi (Tony) Zhou et al. JOURNAL OF PHARMACEUTICAL SCIENCES
- Steroid Nanocrystals Prepared Using the Nano Spray Dryer B-90
- (2013) Koichi Baba et al. Pharmaceutics
- A novel dry powder inhalable formulation incorporating three first-line anti-tubercular antibiotics
- (2012) John Gar Yan Chan et al. EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS
- Developing an efficient and reliable dry powder inhaler for pulmonary drug delivery – A review for multidisciplinary researchers
- (2012) Nazrul Islam et al. MEDICAL ENGINEERING & PHYSICS
- Nano and microparticle engineering of water insoluble drugs using a novel spray-drying process
- (2011) Nina Schafroth et al. COLLOIDS AND SURFACES B-BIOINTERFACES
- Nanonization strategies for poorly water-soluble drugs
- (2010) Huabing Chen et al. DRUG DISCOVERY TODAY
- Formation of Protein Nano-Matrix Particles with Controlled Surface Architecture for Respiratory Drug Delivery
- (2010) Philip Chi Lip Kwok et al. PHARMACEUTICAL RESEARCH
- Preparation and characterisation of controlled release co-spray dried drug–polymer microparticles for inhalation 2: Evaluation of in vitro release profiling methodologies for controlled release respiratory aerosols
- (2008) R SALAMA et al. EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS
- Inhaled nanoparticles—A current review
- (2008) Wei Yang et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- Drug Nanoparticles: Formulating Poorly Water-Soluble Compounds
- (2008) Elaine M. Merisko-Liversidge et al. TOXICOLOGIC PATHOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now